AmerisourceBergen to buy Walgreens’ distribution unit to expand in Europe By Reuters

© Reuters. The logo of Walgreens is seen at their Times Square store in New York

(Reuters) – U.S. drug wholesaler AmerisourceBergen (NYSE:) Corp said on Wednesday it would buy Walgreens Boots Alliance (NASDAQ:)’s drug distribution business for $6.5 billion to expand in Europe.

AmerisourceBergen will pay Walgreens $6.27 billion in cash and deliver 2 million shares of AmerisourceBergen common stock at closing of the transaction.

Walgreens’ unit, Alliance Healthcare is one of the largest drug distributors in Europe. Reuters reported in May that AmerisourceBergen had approached Walgreens to explore a deal for the unit.

With the deal, Walgreens Boots Alliance will be able to increase focus on its core retail pharmacy businesses, which has seen a hit in sales due to the COVID-19 pandemic.

With a 30% stake, Walgreens is the largest shareholder of AmerisourceBergen.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*